- Home
- NVNO vs PSTV Comparison
NVNO vs PSTV Comparison
Compare NVNO & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- PSTV
- Stock Information
- Founded
- NVNO 1987
- PSTV 1996
- Country
- NVNO United States
- PSTV United States
- Employees
- NVNO N/A
- PSTV N/A
- Industry
- NVNO Medical/Dental Instruments
- PSTV Medical/Dental Instruments
- Sector
- NVNO Health Care
- PSTV Health Care
- Exchange
- NVNO Nasdaq
- PSTV Nasdaq
- Market Cap
- NVNO 16.7M
- PSTV 17.0M
- IPO Year
- NVNO N/A
- PSTV N/A
- Fundamental
- Price
- NVNO $0.78
- PSTV $0.45
- Analyst Decision
- NVNO
- PSTV Strong Buy
- Analyst Count
- NVNO 0
- PSTV 4
- Target Price
- NVNO N/A
- PSTV $7.88
- AVG Volume (30 Days)
- NVNO 2.3M
- PSTV 6.5M
- Earning Date
- NVNO 10-30-2025
- PSTV 08-14-2025
- Dividend Yield
- NVNO N/A
- PSTV N/A
- EPS Growth
- NVNO N/A
- PSTV N/A
- EPS
- NVNO N/A
- PSTV N/A
- Revenue
- NVNO N/A
- PSTV $5,317,000.00
- Revenue This Year
- NVNO N/A
- PSTV $2.95
- Revenue Next Year
- NVNO N/A
- PSTV $7.89
- P/E Ratio
- NVNO N/A
- PSTV N/A
- Revenue Growth
- NVNO N/A
- PSTV N/A
- 52 Week Low
- NVNO $0.67
- PSTV $0.16
- 52 Week High
- NVNO $5.70
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- NVNO 20.18
- PSTV 43.96
- Support Level
- NVNO $0.67
- PSTV $0.39
- Resistance Level
- NVNO $1.12
- PSTV $0.52
- Average True Range (ATR)
- NVNO 0.07
- PSTV 0.05
- MACD
- NVNO 0.06
- PSTV -0.00
- Stochastic Oscillator
- NVNO 30.75
- PSTV 33.71
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).